| Year |
Citation |
Score |
| 2024 |
Brown Harding H, Kwaku GN, Reardon CM, Khan NS, Zamith-Miranda D, Zarnowski R, Tam JM, Bohaen CK, Richey L, Mosallanejad K, Crossen AJ, Reedy JL, Ward RA, Vargas-Blanco DA, Basham KJ, ... ... Andes DR, et al. Candida albicans extracellular vesicles trigger type I IFN signalling via cGAS and STING. Nature Microbiology. PMID 38168615 DOI: 10.1038/s41564-023-01546-0 |
0.598 |
|
| 2023 |
Jaromin A, Zarnowski R, Markowski A, Zagórska A, Johnson CJ, Etezadi H, Kihara S, Mota-Santiago P, Nett JE, Boyd BJ, Andes DR. Liposomal formulation of a new antifungal hybrid compound provides protection against in the skin colonization model. Antimicrobial Agents and Chemotherapy. e0095523. PMID 38092678 DOI: 10.1128/aac.00955-23 |
0.655 |
|
| 2023 |
Massey J, Zarnowski R, Andes D. Role of the Extracellular Matrix in Candida Biofilm Antifungal Resistance. Fems Microbiology Reviews. PMID 37816666 DOI: 10.1093/femsre/fuad059 |
0.401 |
|
| 2023 |
Santana DJ, Anku JAE, Zhao G, Zarnowski R, Johnson CJ, Hautau H, Visser ND, Ibrahim AS, Andes D, Nett JE, Singh S, O'Meara TR. A -specific adhesin, Scf1 governs surface association, colonization, and virulence. Science (New York, N.Y.). 381: 1461-1467. PMID 37769084 DOI: 10.1126/science.adf8972 |
0.621 |
|
| 2023 |
Schoen TJ, Calise DG, Bok JW, Giese MA, Nwagwu CD, Zarnowski R, Andes D, Huttenlocher A, Keller NP. Aspergillus fumigatus transcription factor ZfpA regulates hyphal development and alters susceptibility to antifungals and neutrophil killing during infection. Plos Pathogens. 19: e1011152. PMID 37126504 DOI: 10.1371/journal.ppat.1011152 |
0.302 |
|
| 2023 |
Beattie SR, Esan T, Zarnowski R, Eix E, Nett JE, Andes DR, Hagen T, Krysan DJ. Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of Candida albicans Vascular Catheter Infection and Candida auris Skin Colonization. Antimicrobial Agents and Chemotherapy. e0008123. PMID 37097144 DOI: 10.1128/aac.00081-23 |
0.683 |
|
| 2023 |
Andes DR, Nett JE. Analysis of Candida Antifungal Resistance Using Animal Infection Models. Methods in Molecular Biology (Clifton, N.J.). 2658: 225-238. PMID 37024706 DOI: 10.1007/978-1-0716-3155-3_16 |
0.684 |
|
| 2023 |
Beattie SR, Esan T, Zarnowski R, Eix E, Nett JE, Andes DR, Hagen T, Krysan DJ. Novel keto-alkyl-pyridinium antifungal molecules active in models of in vivo vascular catheter infection and ex vivo skin colonization. Biorxiv : the Preprint Server For Biology. PMID 36711909 DOI: 10.1101/2023.01.19.524835 |
0.677 |
|
| 2023 |
Cravener MV, Do E, May G, Zarnowski R, Andes DR, McManus CJ, Mitchell AP. Reinforcement amid genetic diversity in the Candida albicans biofilm regulatory network. Plos Pathogens. 19: e1011109. PMID 36696432 DOI: 10.1371/journal.ppat.1011109 |
0.319 |
|
| 2022 |
Zarnowski R, Sanchez H, Jaromin A, Zarnowska UJ, Nett JE, Mitchell AP, Andes D. A common vesicle proteome drives fungal biofilm development. Proceedings of the National Academy of Sciences of the United States of America. 119: e2211424119. PMID 36095193 DOI: 10.1073/pnas.2211424119 |
0.653 |
|
| 2022 |
Warawa JM, Duan X, Anderson CD, Sotsky JB, Cramer DE, Pfeffer TL, Guo H, Adcock S, Lepak AJ, Andes DR, Slone SA, Stromberg AJ, Gabbard JD, Severson WE, Lawrenz MB. Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains. Microbiology Spectrum. e0269322. PMID 36094219 DOI: 10.1128/spectrum.02693-22 |
0.352 |
|
| 2022 |
Hereidia M, Andes D. Production and Isolation of the Candida Species Biofilm Extracellular Matrix. Methods in Molecular Biology (Clifton, N.J.). 2542: 257-268. PMID 36008671 DOI: 10.1007/978-1-0716-2549-1_19 |
0.309 |
|
| 2022 |
Revie NM, Iyer KR, Maxson ME, Zhang J, Yan S, Fernandes CM, Meyer KJ, Chen X, Skulska I, Fogal M, Sanchez H, Hossain S, Li S, Yashiroda Y, Hirano H, ... ... Andes DR, et al. Targeting fungal membrane homeostasis with imidazopyrazoindoles impairs azole resistance and biofilm formation. Nature Communications. 13: 3634. PMID 35752611 DOI: 10.1038/s41467-022-31308-1 |
0.359 |
|
| 2022 |
Heredia M, Andes D. Contributions of Extracellular Vesicles to Fungal Biofilm Pathogenesis. Current Topics in Microbiology and Immunology. 432: 67-79. PMID 34972879 DOI: 10.1007/978-3-030-83391-6_7 |
0.336 |
|
| 2021 |
Asker D, Awad TS, Raju D, Sanchez H, Lacdao I, Gilbert S, Sivarajah P, Andes DR, Sheppard DC, Howell PL, Hatton BD. Preventing Biofilms on Indwelling Catheters by Surface-Bound Enzymes. Acs Applied Bio Materials. 4: 8248-8258. PMID 35005941 DOI: 10.1021/acsabm.1c00794 |
0.331 |
|
| 2021 |
Zarnowski R, Noll A, Chevrette MG, Sanchez H, Jones R, Anhalt H, Fossen J, Jaromin A, Currie C, Nett JE, Mitchell A, Andes DR. Coordination of fungal biofilm development by extracellular vesicle cargo. Nature Communications. 12: 6235. PMID 34716343 DOI: 10.1038/s41467-021-26525-z |
0.688 |
|
| 2021 |
Zarnowski R, Sanchez H, Andreu C, Andes D, Del Olmo ML. Formation and characterization of biofilms formed by salt-tolerant yeast strains in seawater-based growth medium. Applied Microbiology and Biotechnology. PMID 33630153 DOI: 10.1007/s00253-021-11132-1 |
0.336 |
|
| 2020 |
Zarnowski R, Jaromin A, Zagórska A, Dominguez EG, Sidoryk K, Gubernator J, Andes DR. A Label-Free Cellular Proteomics Approach to Decipher the Antifungal Action of DiMIQ, a Potent Indolo[2,3-]Quinoline Agent, against Biofilms. International Journal of Molecular Sciences. 22. PMID 33374351 DOI: 10.3390/ijms22010108 |
0.322 |
|
| 2020 |
Zhao M, Zhang F, Zarnowski R, Barns KJ, Jones R, Fossen JL, Sanchez H, Rajski SR, Audhya A, Bugni TS, Andes DR. Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking. The Journal of Clinical Investigation. PMID 33373326 DOI: 10.1172/JCI145123 |
0.406 |
|
| 2020 |
Iyer KR, Camara K, Daniel-Ivad M, Trilles R, Pimentel-Elardo SM, Fossen JL, Marchillo K, Liu Z, Singh S, Muñoz JF, Kim SH, Porco JA, Cuomo CA, Williams NS, Ibrahim AS, ... ... Andes DR, et al. An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris. Nature Communications. 11: 6429. PMID 33353950 DOI: 10.1038/s41467-020-20183-3 |
0.342 |
|
| 2020 |
Lepak AJ, Wang W, Andes DR. Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models Against Gram-Negative Pathogens. Antimicrobial Agents and Chemotherapy. PMID 32868332 DOI: 10.1128/Aac.01517-20 |
0.373 |
|
| 2020 |
Johnson MD, Lewis RE, Dodds Ashley ES, Ostrosky-Zeichner L, Zaoutis T, Thompson GR, Andes DR, Walsh TJ, Pappas PG, Cornely OA, Perfect JR, Kontoyiannis DP. Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium. The Journal of Infectious Diseases. 222: S175-S198. PMID 32756879 DOI: 10.1093/Infdis/Jiaa394 |
0.312 |
|
| 2020 |
Ambrose PG, Bhavnani SM, Andes DR, Bradley JS, Flamm RK, Pogue JM, Jones RN. Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients. Open Forum Infectious Diseases. 7: ofaa084. PMID 32667364 DOI: 10.1093/Ofid/Ofaa084 |
0.352 |
|
| 2020 |
Nett JE, Andes DR. Contributions of the Biofilm Matrix to Pathogenesis. Journal of Fungi (Basel, Switzerland). 6. PMID 32028622 DOI: 10.3390/Jof6010021 |
0.692 |
|
| 2020 |
Wicha WW, Craig WA, Andes D. In vivo pharmacodynamics of lefamulin, the first systemic pleuromutilin for human use, in a neutropenic murine thigh infection model. The Journal of Antimicrobial Chemotherapy. 74: iii5-iii10. PMID 30949706 DOI: 10.1093/Jac/Dkz085 |
0.307 |
|
| 2019 |
Pogue JM, Jones RN, Bradley JS, Andes DR, Bhavnani SM, Drusano GL, Dudley MN, Flamm RK, Rodvold KA, Ambrose PG. Polymyxin susceptibility testing and interpretive breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST). Antimicrobial Agents and Chemotherapy. PMID 31767718 DOI: 10.1128/Aac.01495-19 |
0.358 |
|
| 2019 |
Lepak AJ, Zhao M, Marchillo K, VanHecker J, Andes DR. Pharmacodynamic Evaluation of Omadacycline against in the Neutropenic Mouse Pneumonia Model. Antimicrobial Agents and Chemotherapy. PMID 31712210 DOI: 10.1128/Aac.02058-19 |
0.337 |
|
| 2019 |
Mevers E, Saurí J, Helfrich EJN, Henke M, Barns KJ, Bugni TS, Andes DR, Currie CR, Clardy J. Pyonitrins A-D: Chimeric natural products produced by Pseudomonas protegens. Journal of the American Chemical Society. PMID 31600443 DOI: 10.1021/Jacs.9B09739 |
0.319 |
|
| 2019 |
Lepak AJ, Zhao M, Andes DR. WCK 5222 (Cefepime/Zidebactam) Pharmacodynamic Target Analysis against Metallo-β-lactamase producing in the Neutropenic Mouse Pneumonia Model. Antimicrobial Agents and Chemotherapy. PMID 31591114 DOI: 10.1128/Aac.01648-19 |
0.332 |
|
| 2019 |
Lepak AJ, Zhao M, Andes DR. Determination of Pharmacodynamic Target Exposures for Rezafungin against and in the Neutropenic Mouse Disseminated Candidiasis Model. Antimicrobial Agents and Chemotherapy. PMID 31481440 DOI: 10.1128/Aac.01556-19 |
0.349 |
|
| 2019 |
Rai LS, Singha R, Sanchez H, Chakraborty T, Chand B, Bachellier-Bassi S, Chowdhury S, d'Enfert C, Andes DR, Sanyal K. The Candida albicans biofilm gene circuit modulated at the chromatin level by a recent molecular histone innovation. Plos Biology. 17: e3000422. PMID 31398188 DOI: 10.1371/Journal.Pbio.3000422 |
0.424 |
|
| 2019 |
Jorgenson M, Descourouez JL, Marka N, Leverson G, Smith J, Andes D, Fernandez L, Foley D. A Targeted Fungal Prophylaxis Protocol with Static Dosed Fluconazole Significantly Reduces Invasive Fungal Infection after Liver Transplantation. Transplant Infectious Disease : An Official Journal of the Transplantation Society. PMID 31390109 DOI: 10.1111/Tid.13156 |
0.33 |
|
| 2019 |
Zhao M, Lepak AJ, Marchillo K, Andes DR. Pharmacodynamic Target Determination for Delafloxacin against and in the Neutropenic Murine Pneumonia Model. Antimicrobial Agents and Chemotherapy. PMID 31332063 DOI: 10.1128/Aac.01131-19 |
0.36 |
|
| 2019 |
McCreary EK, Bayless M, Van AP, Lepak AJ, Wiebe DA, Schulz LT, Andes DR. Impact of triazole therapeutic drug monitoring availability and timing. Antimicrobial Agents and Chemotherapy. PMID 31332058 DOI: 10.1128/Aac.01245-19 |
0.306 |
|
| 2019 |
Rodríguez López AL, Lee MR, Wang NB, Dunn KK, Sanchez H, Raman N, Andes DR, Lynn DM, Palecek SP. Small-molecule morphogenesis modulators enhance the ability of 14-helical β-peptides to prevent biofilm formation. Antimicrobial Agents and Chemotherapy. PMID 31209011 DOI: 10.1128/Aac.02653-18 |
0.385 |
|
| 2019 |
Okusanya OO, Forrest A, Bhavnani SM, Fernandes P, Ambrose PG, Andes DR. Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin Against Using Data from a Neutropenic Murine-Lung Infection Model. Antimicrobial Agents and Chemotherapy. PMID 31182534 DOI: 10.1128/Aac.02606-18 |
0.395 |
|
| 2019 |
Lepak AJ, Zhao M, Marchillo K, VanHecker J, Andes DR. Pharmacodynamics of Omadacycline against in the Neutropenic Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. PMID 31036691 DOI: 10.1128/Aac.00624-19 |
0.399 |
|
| 2019 |
Misch EA, Andes DR. Bacterial Infections in the Stem Cell Transplant Recipient and Hematologic Malignancy Patient. Infectious Disease Clinics of North America. 33: 399-445. PMID 31005135 DOI: 10.1016/J.Idc.2019.02.011 |
0.376 |
|
| 2019 |
Chevrette MG, Carlson CM, Ortega HE, Thomas C, Ananiev GE, Barns KJ, Book AJ, Cagnazzo J, Carlos C, Flanigan W, Grubbs KJ, Horn HA, Hoffmann FM, Klassen JL, Knack JJ, ... ... Andes DR, et al. The antimicrobial potential of Streptomyces from insect microbiomes. Nature Communications. 10: 516. PMID 30705269 DOI: 10.1038/S41467-019-08438-0 |
0.389 |
|
| 2019 |
Zhao M, Lepak AJ, Marchillo K, Vanhecker J, Sanchez H, Ambrose PG, Andes DR. APX001 Pharmacokinetic/Pharmacodynamic Target Determination against in an Model of Invasive Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy. PMID 30670426 DOI: 10.1128/Aac.02372-18 |
0.331 |
|
| 2019 |
Dominguez EG, Zarnowski R, Choy HL, Zhao M, Sanchez H, Nett JE, Andes DR. Conserved Role for Biofilm Matrix Polysaccharides in Drug Resistance. Msphere. 4. PMID 30602527 DOI: 10.1128/mSphereDirect.00680-18 |
0.705 |
|
| 2019 |
Pogue JM, Jones RN, Bradley JS, Andes D, Bhavnani SM, Dudley M, Flamm RK, Rodvold KA, Ambrose PG. 1534. Polymyxin Antimicrobial Susceptibility (AST) Testing and Breakpoints for P. aeruginosa, A. baumannii, and Enterobacteriaceae: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST) Open Forum Infectious Diseases. 6: S559-S559. DOI: 10.1093/Ofid/Ofz360.1398 |
0.383 |
|
| 2018 |
Robinett NG, Culbertson EM, Peterson RL, Sanchez H, Andes D, Nett JE, Culotta VC. Exploiting the vulnerable active site of a copper-only superoxide dismutase to disrupt fungal pathogenesis. The Journal of Biological Chemistry. PMID 30593499 DOI: 10.1074/Jbc.Ra118.007095 |
0.601 |
|
| 2018 |
Bader JC, Lakota EA, Andes DR, Rubino CM, Ambrose PG, Bhavnani SM. Time for Precision: A World Without Susceptibility Breakpoints. Open Forum Infectious Diseases. 5: ofy282. PMID 30581880 DOI: 10.1093/Ofid/Ofy282 |
0.339 |
|
| 2018 |
Lepak AJ, Zhao M, Liu Q, Wang P, Wang Y, Bader JC, Ambrose PG, Andes DR. Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against and . Antimicrobial Agents and Chemotherapy. PMID 30559140 DOI: 10.1128/Aac.02404-18 |
0.368 |
|
| 2018 |
Koo H, Andes DR, Krysan DJ. Candida-streptococcal interactions in biofilm-associated oral diseases. Plos Pathogens. 14: e1007342. PMID 30543717 DOI: 10.1371/Journal.Ppat.1007342 |
0.356 |
|
| 2018 |
Andes DR, Ghannoum MA, Mukherjee PK, Kovanda LL, Lu Q, Jones ME, Santerre Henriksen A, Lademacher C, Hope WW. Outcomes by Minimum Inhibitory Concentrations for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials. Antimicrobial Agents and Chemotherapy. PMID 30373791 DOI: 10.1128/Aac.01634-18 |
0.327 |
|
| 2018 |
Zarnowski R, Sanchez H, Covelli AS, Dominguez E, Jaromin A, Berhardt J, Heiss C, Azadi P, Mitchell A, Andes DR. Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis. Plos Biology. 16: e2006872. PMID 30296253 DOI: 10.1371/Journal.Pbio.2006872 |
0.476 |
|
| 2018 |
Lepak AJ, Zhao M, Andes DR. Pharmacodynamic Evaluation of Rezafungin (CD101) Against in the Neutropenic Mouse Invasive Candidiasis Model. Antimicrobial Agents and Chemotherapy. PMID 30181375 DOI: 10.1128/Aac.01572-18 |
0.348 |
|
| 2018 |
Dijck PV, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, et al. Methodologies for and evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms. Microbial Cell (Graz, Austria). 5: 300-326. PMID 29992128 DOI: 10.15698/Mic2018.07.638 |
0.693 |
|
| 2018 |
Zhao M, Lepak AJ, Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Characterization of a Novel Antibiotic Odilorhabdins, NOSO-502 against and in a Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. PMID 29987156 DOI: 10.1128/Aac.01067-18 |
0.36 |
|
| 2018 |
Owens RC, Bulik CC, Andes DR. Pharmacokinetics-pharmacodynamics, computer decision support technologies, and antimicrobial stewardship: the compass and rudder. Diagnostic Microbiology and Infectious Disease. PMID 29776710 DOI: 10.1016/J.Diagmicrobio.2018.03.015 |
0.33 |
|
| 2018 |
Kim D, Liu Y, Benhamou RI, Sanchez H, Simón-Soro Á, Li Y, Hwang G, Fridman M, Andes DR, Koo H. Bacterial-derived exopolysaccharides enhance antifungal drug tolerance in a cross-kingdom oral biofilm. The Isme Journal. PMID 29670217 DOI: 10.1038/S41396-018-0113-1 |
0.511 |
|
| 2018 |
Dominguez E, Zarnowski R, Sanchez H, Covelli AS, Westler WM, Azadi P, Nett J, Mitchell AP, Andes DR. Conservation and Divergence in theSpecies Biofilm Matrix Mannan-Glucan Complex Structure, Function, and Genetic Control. Mbio. 9. PMID 29615504 DOI: 10.1128/Mbio.00451-18 |
0.682 |
|
| 2018 |
Park JH, Craig W, Marchillo K, Huang DB, Andes DR. Identification of the In Vivo Pharmacokinetics and Pharmacodynamic Drivers of Iclaprim. Antimicrobial Agents and Chemotherapy. PMID 29378717 DOI: 10.1128/Aac.02550-17 |
0.317 |
|
| 2018 |
Zhao M, Lepak AJ, VanScoy B, Bader JC, Marchillo K, Vanhecker J, Ambrose PG, Andes DR. In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model. Antimicrobial Agents and Chemotherapy. PMID 29378706 DOI: 10.1128/Aac.02542-17 |
0.326 |
|
| 2018 |
Bader JC, Bhavnani SM, Andes DR, Ambrose PG. We can do better: a fresh look at echinocandin dosing. The Journal of Antimicrobial Chemotherapy. 73: i44-i50. PMID 29304211 DOI: 10.1093/Jac/Dkx448 |
0.387 |
|
| 2018 |
McCreary EK, Borlagdan J, Andes DR, Kinn P, Schulz LT, Lepak AJ. 406. Achievement of Clinical Isavuconazole (ISA) Serum and Plasma Drug Concentrations in Two Patients With Isavuconazonium Capsules Administered via Nasogastric Feeding Tube (NGT) Open Forum Infectious Diseases. 5: S156-S156. DOI: 10.1093/Ofid/Ofy210.417 |
0.319 |
|
| 2018 |
Lepak AJ, Zhao M, Liu Q, Wang P, Wang Y, Bader JC, Ambrose PG, Andes DR. 1389. Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model Against S. aureus (SA) and S. pneumoniae (SPN) Open Forum Infectious Diseases. 5: S426-S426. DOI: 10.1093/Ofid/Ofy210.1220 |
0.335 |
|
| 2018 |
Zhao M, Lepak AJ, Andes DR. 1383. In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of NOSO-502, a First-in-Class Odilorhabdin Antibiotic, Against E. coli (EC) and K. pneumoniae (KPN) in the Murine Neutropenic Thigh Model Open Forum Infectious Diseases. 5: S424-S424. DOI: 10.1093/Ofid/Ofy210.1214 |
0.301 |
|
| 2018 |
Bhavnani SM, Onufrak NJ, Hammel JP, Andes DR, Bradley JS, Flamm RK, Ambrose PG, Jones RN. 2562. Re-Appraisal of Aminoglycoside (AG) Susceptibility Testing Breakpoints Based on the Application of Pharmacokinetics–Pharmacodynamics (PK-PD) and Contemporary Microbiology Surveillance Data Open Forum Infectious Diseases. 5: S71-S71. DOI: 10.1093/Ofid/Ofy209.170 |
0.309 |
|
| 2017 |
Lepak AJ, Zhao M, VanScoy B, Ambrose PG, Andes DR. Pharmacodynamics of the Long Acting Echinocandin, CD101, in the Neutropenic Invasive Candidiasis Murine Model Using an Extended Interval Dosing Design. Antimicrobial Agents and Chemotherapy. PMID 29203480 DOI: 10.1128/Aac.02154-17 |
0.329 |
|
| 2017 |
Rossi DCP, Gleason JE, Sanchez H, Schatzman SS, Culbertson EM, Johnson CJ, McNees CA, Coelho C, Nett JE, Andes DR, Cormack BP, Culotta VC. Candida albicans FRE8 encodes a member of the NADPH oxidase family that produces a burst of ROS during fungal morphogenesis. Plos Pathogens. 13: e1006763. PMID 29194441 DOI: 10.1371/Journal.Ppat.1006763 |
0.652 |
|
| 2017 |
Andes DR, Lepak AJ. In vivo infection models in the pre-clinical pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents. Current Opinion in Pharmacology. 36: 94-99. PMID 28964956 DOI: 10.1016/J.Coph.2017.09.004 |
0.353 |
|
| 2017 |
Desai AV, Kovanda LL, Hope WW, Andes D, Mouton JW, Kowalski DL, Townsend RW, Mujais S, Bonate PL. Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi. Antimicrobial Agents and Chemotherapy. PMID 28923872 DOI: 10.1128/Aac.01034-17 |
0.306 |
|
| 2017 |
Ostrosky-Zeichner L, Andes D. The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus. The Journal of Infectious Diseases. 216: S452-S457. PMID 28911047 DOI: 10.1093/Infdis/Jix239 |
0.348 |
|
| 2017 |
Srivastava A, Sircaik S, Husain F, Thomas E, Ror S, Rastogi S, Alim D, Bapat P, Andes DR, Nobile CJ, Panwar SL. Distinct roles of the 7-transmembrane receptor protein Rta3 in regulating the asymmetric distribution of phosphatidylcholine across the plasma membrane and biofilm formation in Candida albicans. Cellular Microbiology. PMID 28745020 DOI: 10.1111/Cmi.12767 |
0.411 |
|
| 2017 |
Lepak AJ, Zhao M, Berkow EL, Lockhart SR, Andes DR. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection. Antimicrobial Agents and Chemotherapy. PMID 28584152 DOI: 10.1093/Ofid/Ofx163.004 |
0.394 |
|
| 2017 |
Zhao M, Lepak AJ, Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Target Assessment of Eravacycline against Escherichia Coli in a Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. PMID 28416552 DOI: 10.1128/Aac.00250-17 |
0.371 |
|
| 2017 |
Lepak AJ, Zhao M, Andes DR. Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. PMID 28416551 DOI: 10.1128/Aac.00281-17 |
0.38 |
|
| 2017 |
Lepak AJ, Zhao M, VanScoy B, Taylor DS, Ellis-Grosse E, Ambrose PG, Andes DR. In vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against E. coli, K. pneumoniae, and P. aeruginosa. Antimicrobial Agents and Chemotherapy. PMID 28396549 DOI: 10.1128/Aac.00476-17 |
0.389 |
|
| 2017 |
Lepak AJ, Zhao M, Marchillo K, VanHecker J, Andes DR. In vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model. Antimicrobial Agents and Chemotherapy. PMID 28193651 DOI: 10.1128/Aac.02368-16 |
0.377 |
|
| 2017 |
Lepak AJ, Zhao M, Marchillo K, VanHecker J, Andes DR. In vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Staphylococcus aureus (SA) in the Murine Thigh Infection Model Open Forum Infectious Diseases. 4: S478-S479. DOI: 10.1093/Ofid/Ofx163.1227 |
0.359 |
|
| 2017 |
Gleason J, Rossi D, Sanchez H, McNees C, Schatzman S, Culbertson E, Johnson C, Nett J, Andes D, Cormack B, Culotta V. Candida Albicans FRE8 Encodes a Member of the NADPH Oxidase Family that Produces a Burst of ROS Important for Morphogenesis Free Radical Biology and Medicine. 112: 194-195. DOI: 10.1016/J.Freeradbiomed.2017.10.307 |
0.657 |
|
| 2016 |
Woolford CA, Lagree K, Xu W, Aleynikov T, Adhikari H, Sanchez H, Cullen PJ, Lanni F, Andes DR, Mitchell AP. Bypass of Candida albicans Filamentation/Biofilm Regulators through Diminished Expression of Protein Kinase Cak1. Plos Genetics. 12: e1006487. PMID 27935965 DOI: 10.1371/Journal.Pgen.1006487 |
0.376 |
|
| 2016 |
Zhao M, Lepak AJ, Andes DR. Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents. Bioorganic & Medicinal Chemistry. PMID 27887963 DOI: 10.1016/J.Bmc.2016.11.008 |
0.355 |
|
| 2016 |
Bulik CC, Okusanya ÓO, Lakota EA, Forrest A, Bhavnani SM, Hoover JL, Andes DR, Ambrose PG. Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin Against Gram-Positive Organisms Using Data From Murine Infection Models. Antimicrobial Agents and Chemotherapy. PMID 27872075 DOI: 10.1128/Aac.00115-16 |
0.397 |
|
| 2016 |
Zarnowski R, Sanchez H, Andes DR. Large-scale production and isolation of Candida biofilm extracellular matrix. Nature Protocols. 11: 2320-2327. PMID 27809313 DOI: 10.1038/Nprot.2016.132 |
0.416 |
|
| 2016 |
Kong EF, Tsui C, Kucharíková S, Andes D, Van Dijck P, Jabra-Rizk MA. Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix. Mbio. 7. PMID 27729510 DOI: 10.1128/Mbio.01365-16 |
0.541 |
|
| 2016 |
Mitchell KF, Zarnowski R, Andes DR. Fungal Super Glue: The Biofilm Matrix and Its Composition, Assembly, and Functions. Plos Pathogens. 12: e1005828. PMID 27685086 DOI: 10.1371/Journal.Ppat.1005828 |
0.349 |
|
| 2016 |
Winter MB, Salcedo EC, Lohse MB, Hartooni N, Gulati M, Sanchez H, Takagi J, Hube B, Andes DR, Johnson AD, Craik CS, Nobile CJ. Global Identification of Biofilm-Specific Proteolysis in Candida albicans. Mbio. 7. PMID 27624133 DOI: 10.1128/Mbio.01514-16 |
0.501 |
|
| 2016 |
Shekhar-Guturja T, Gunaherath GM, Wijeratne EM, Lambert JP, Averette AF, Lee SC, Kim T, Bahn YS, Tripodi F, Ammar R, Döhl K, Niewola-Staszkowska K, Schmitt L, Loewith RJ, Roth FP, ... ... Andes D, et al. Dual action antifungal small molecule modulates multidrug efflux and TOR signaling. Nature Chemical Biology. PMID 27571477 DOI: 10.1038/Nchembio.2165 |
0.406 |
|
| 2016 |
Mitchell KF, Zarnowski R, Andes DR. The Extracellular Matrix of Fungal Biofilms. Advances in Experimental Medicine and Biology. PMID 27271680 DOI: 10.1007/5584_2016_6 |
0.455 |
|
| 2016 |
Lepak AJ, Andes DR. In vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in the Murine Lung Infection Model. Antimicrobial Agents and Chemotherapy. PMID 27216072 DOI: 10.1128/Aac.00647-16 |
0.365 |
|
| 2016 |
Khandelwal NK, Kaemmer P, Förster TM, Singh A, Coste AT, Andes DR, Hube B, Sanglard D, Chauhan N, Kaur R, d'Enfert C, Mondal AK, Prasad R. Pleiotropic effects of the vacuolar ABC transporter MLT1 of Candida albicans on cell function and virulence. The Biochemical Journal. PMID 27026051 DOI: 10.1042/Bcj20160024 |
0.346 |
|
| 2016 |
Nett JE, Cabezas-Olcoz J, Marchillo K, Mosher DF, Andes DR. Targeting fibronectin to disrupt in vivo Candida biofilms. Antimicrobial Agents and Chemotherapy. PMID 26902759 DOI: 10.1128/Aac.03094-15 |
0.701 |
|
| 2016 |
Raman N, Marchillo K, Lee MR, Rodríguez López AL, Andes DR, Palecek SP, Lynn DM. Intraluminal Release of an Antifungal β-Peptide Enhances the Antifungal and Anti-Biofilm Activities of Multilayer-Coated Catheters in a Rat Model of Venous Catheter Infection. Acs Biomaterials Science & Engineering. 2: 112-121. PMID 26807439 DOI: 10.1021/Acsbiomaterials.5B00427 |
0.34 |
|
| 2016 |
Nett JE, Andes DR. Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Infectious Disease Clinics of North America. 30: 51-83. PMID 26739608 DOI: 10.1016/J.Idc.2015.10.012 |
0.629 |
|
| 2016 |
Lepak AJ, Seiler P, Surivet JP, Ritz D, Kohl C, Andes DR. In vivo pharmacodynamic target investigation of two bacterial topoisomerase inhibitors, ACT-387042 and ACT-292706, in the neutropenic murine thigh model against Streptococcus pneumoniae and Staphylococcus aureus Antimicrobial Agents and Chemotherapy. 60: 3626-3632. DOI: 10.1128/Aac.00363-16 |
0.43 |
|
| 2016 |
Bhavnani SM, Zhang L, Rubino CM, Bader JC, Lepak AJ, Andes DR, Flamm RK, Cammarata SK, Ambrose PG. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses for Delafloxacin to Provide Dose Selection Support for the Treatment of Patients With Community-Acquired Bacterial Pneumonia (CABP) Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1520 |
0.306 |
|
| 2016 |
Lepak A, Zhao M, Marchillo K, Vanhecker J, Smart JI, Bruss J, Andes D. Comparative In Vivo Pharmacokinetics/Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh Infection Model Against Staphylococcus aureus Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1496 |
0.385 |
|
| 2015 |
Walsh TJ, Azie N, Andes DR. Development of New Strategies for Echinocandins: Progress in Translational Research. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: S601-3. PMID 26567276 DOI: 10.1093/Cid/Civ676 |
0.352 |
|
| 2015 |
Nett JE, Andes DR. Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs. Microbiology Spectrum. 3. PMID 26397003 DOI: 10.1128/Microbiolspec.Mb-0008-2014 |
0.736 |
|
| 2015 |
Lepak A, Marchillo K, VanHecker J, Andes D. Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target. Antimicrobial Agents and Chemotherapy. 59: 7833-6. PMID 26392492 DOI: 10.1128/Aac.01717-15 |
0.415 |
|
| 2015 |
Nett JE, Zarnowski R, Cabezas-Olcoz J, Brooks EG, Bernhardt J, Marchillo K, Mosher DF, Andes DR. Host Contributions to Construction of Three Device-Associated Candida albicans Biofilms. Infection and Immunity. 83: 4630-8. PMID 26371129 DOI: 10.1128/Iai.00931-15 |
0.689 |
|
| 2015 |
Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Brüggemann RJ, Chowdhary A, Cornely OA, Denning DW, Groll AH, Izumikawa K, Kullberg BJ, Lagrou K, Maertens J, Meis JF, Newton P, et al. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 21: 30-40. PMID 26282594 DOI: 10.1016/J.Drup.2015.08.001 |
0.348 |
|
| 2015 |
Lepak AJ, Parhi A, Madison M, Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model. Antimicrobial Agents and Chemotherapy. 59: 6568-74. PMID 26259789 DOI: 10.1128/Aac.01464-15 |
0.417 |
|
| 2015 |
Davis SA, Vincent BM, Endo MM, Whitesell L, Marchillo K, Andes DR, Lindquist S, Burke MD. Nontoxic antimicrobials that evade drug resistance. Nature Chemical Biology. 11: 481-7. PMID 26030729 DOI: 10.1038/Nchembio.1821 |
0.368 |
|
| 2015 |
van der Linden JW, Arendrup MC, Warris A, Lagrou K, Pelloux H, Hauser PM, Chryssanthou E, Mellado E, Kidd SE, Tortorano AM, Dannaoui E, Gaustad P, Baddley JW, Uekötter A, Lass-Flörl C, ... ... Andes D, et al. Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerging Infectious Diseases. 21: 1041-4. PMID 25988348 DOI: 10.3201/Eid2106.140717 |
0.328 |
|
| 2015 |
Fox EP, Bui CK, Nett JE, Hartooni N, Mui MC, Andes DR, Nobile CJ, Johnson AD. An expanded regulatory network temporally controls Candida albicans biofilm formation. Molecular Microbiology. 96: 1226-39. PMID 25784162 DOI: 10.1111/Mmi.13002 |
0.714 |
|
| 2015 |
Mitchell KF, Zarnowski R, Sanchez H, Edward JA, Reinicke EL, Nett JE, Mitchell AP, Andes DR. Community participation in biofilm matrix assembly and function. Proceedings of the National Academy of Sciences of the United States of America. 112: 4092-7. PMID 25770218 DOI: 10.1073/Pnas.1421437112 |
0.671 |
|
| 2015 |
Lepak AJ, Marchillo K, Andes DR. Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model. Antimicrobial Agents and Chemotherapy. 59: 1265-72. PMID 25512406 DOI: 10.1128/Aac.04445-14 |
0.367 |
|
| 2015 |
Lepak AJ, Marchillo K, Craig WA, Andes DR. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model. Antimicrobial Agents and Chemotherapy. 59: 1258-64. PMID 25512404 DOI: 10.1128/Aac.04444-14 |
0.37 |
|
| 2015 |
Lepak AJ, Andes DR. Antifungal pharmacokinetics and pharmacodynamics. Cold Spring Harbor Perspectives in Medicine. 5: a019653. PMID 25384765 DOI: 10.1101/Cshperspect.A019653 |
0.371 |
|
| 2015 |
Andes D, Azie N, Yang H, Kelley C, Tan R, Zhong Y, Franks B, Kristy R, Lee E, Khandelwal N, Spalding J. Evaluation of Prevalence of Potential Drug-Drug Interaction Among Patients With Invasive Fungal Infections Receiving Mold-Active Triazoles Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.863 |
0.348 |
|
| 2015 |
Lepak A, Andes D. Pharmacodynamic (PD) Activity of Dalbavancin Against VISA Staphylococcus aureus(SA) Isolates in the Neutropenic Murine Thigh Infection Model Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.515 |
0.334 |
|
| 2014 |
Desai JV, Mitchell AP, Andes DR. Fungal biofilms, drug resistance, and recurrent infection. Cold Spring Harbor Perspectives in Medicine. 4. PMID 25274758 DOI: 10.1101/Cshperspect.A019729 |
0.493 |
|
| 2014 |
Holland LM, Schröder MS, Turner SA, Taff H, Andes D, Grózer Z, Gácser A, Ames L, Haynes K, Higgins DG, Butler G. Comparative phenotypic analysis of the major fungal pathogens Candida parapsilosis and Candida albicans. Plos Pathogens. 10: e1004365. PMID 25233198 DOI: 10.1371/Journal.Ppat.1004365 |
0.81 |
|
| 2014 |
Nett JE, Brooks EG, Cabezas-Olcoz J, Sanchez H, Zarnowski R, Marchillo K, Andes DR. Rat indwelling urinary catheter model of Candida albicans biofilm infection. Infection and Immunity. 82: 4931-40. PMID 25183731 DOI: 10.1128/Iai.02284-14 |
0.739 |
|
| 2014 |
Zarnowski R, Westler WM, Lacmbouh GA, Marita JM, Bothe JR, Bernhardt J, Lounes-Hadj Sahraoui A, Fontaine J, Sanchez H, Hatfield RD, Ntambi JM, Nett JE, Mitchell AP, Andes DR. Novel entries in a fungal biofilm matrix encyclopedia. Mbio. 5: e01333-14. PMID 25096878 DOI: 10.1128/Mbio.01333-14 |
0.675 |
|
| 2014 |
Lepak AJ, Reda A, Marchillo K, Van Hecker J, Craig WA, Andes D. Impact of MIC range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the ceftolozane in vivo pharmacokinetic/pharmacodynamic target. Antimicrobial Agents and Chemotherapy. 58: 6311-4. PMID 25092700 DOI: 10.1128/Aac.03572-14 |
0.429 |
|
| 2014 |
Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, Franks B, Azie NE. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008. Plos One. 9: e101510. PMID 24991967 DOI: 10.1371/Journal.Pone.0101510 |
0.324 |
|
| 2014 |
Nobile CJ, Fox EP, Hartooni N, Mitchell KF, Hnisz D, Andes DR, Kuchler K, Johnson AD. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans. Mbio. 5: e01201-14. PMID 24917598 DOI: 10.1128/Mbio.01201-14 |
0.514 |
|
| 2014 |
Lewis JS, Lepak AJ, Thompson GR, Craig WA, Andes DR, Sabol-Dzintars KE, Jorgensen JH. Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections. Antimicrobial Agents and Chemotherapy. 58: 1327-31. PMID 24323478 DOI: 10.1128/Aac.01877-13 |
0.355 |
|
| 2013 |
Taff HT, Marchillo K, Andes DR. Preparation of Candida albicans Biofilms Using an in vivo Rat Central Venous Catheter Model. Bio-Protocol. 3. PMID 25927075 |
0.819 |
|
| 2013 |
Taff HT, Andes DR. Preparation of Candida albicans Biofilms for Transmission Electron Microscopy. Bio-Protocol. 3. PMID 25927074 |
0.783 |
|
| 2013 |
Lepak AJ, Marchillo K, Vanhecker J, Andes DR. Isavuconazole (BAL4815) pharmacodynamic target determination in an in vivo murine model of invasive pulmonary aspergillosis against wild-type and cyp51 mutant isolates of Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy. 57: 6284-9. PMID 24100500 DOI: 10.1128/Aac.01355-13 |
0.374 |
|
| 2013 |
Taff HT, Mitchell KF, Edward JA, Andes DR. Mechanisms of Candida biofilm drug resistance. Future Microbiology. 8: 1325-37. PMID 24059922 DOI: 10.2217/Fmb.13.101 |
0.827 |
|
| 2013 |
Andes D, Casadevall A. Insights into fungal pathogenesis from the iatrogenic epidemic of Exserohilum rostratum fungal meningitis. Fungal Genetics and Biology : Fg & B. 61: 143-5. PMID 24012946 DOI: 10.1016/J.Fgb.2013.08.014 |
0.347 |
|
| 2013 |
Lepak AJ, Marchillo K, VanHecker J, Diekema D, Andes DR. Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis model. Antimicrobial Agents and Chemotherapy. 57: 5642-8. PMID 24002092 DOI: 10.1128/Aac.01354-13 |
0.342 |
|
| 2013 |
Zhang J, Ponomareva LV, Marchillo K, Zhou M, Andes DR, Thorson JS. Synthesis and antibacterial activity of doxycycline neoglycosides. Journal of Natural Products. 76: 1627-36. PMID 23987662 DOI: 10.1021/Np4003096 |
0.365 |
|
| 2013 |
Lepak AJ, Marchillo K, VanHecker J, Andes DR. Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates. Antimicrobial Agents and Chemotherapy. 57: 5438-47. PMID 23959322 DOI: 10.1128/Aac.00833-13 |
0.398 |
|
| 2013 |
Green JV, Orsborn KI, Zhang M, Tan QK, Greis KD, Porollo A, Andes DR, Long Lu J, Hostetter MK. Heparin-binding motifs and biofilm formation by Candida albicans. The Journal of Infectious Diseases. 208: 1695-704. PMID 23904295 DOI: 10.1093/Infdis/Jit391 |
0.41 |
|
| 2013 |
Connolly LA, Riccombeni A, Grózer Z, Holland LM, Lynch DB, Andes DR, Gácser A, Butler G. The APSES transcription factor Efg1 is a global regulator that controls morphogenesis and biofilm formation in Candida parapsilosis. Molecular Microbiology. 90: 36-53. PMID 23895281 DOI: 10.1111/Mmi.12345 |
0.401 |
|
| 2013 |
Palmer JM, Bok JW, Lee S, Dagenais TR, Andes DR, Kontoyiannis DP, Keller NP. Loss of CclA, required for histone 3 lysine 4 methylation, decreases growth but increases secondary metabolite production in Aspergillus fumigatus. Peerj. 1: e4. PMID 23638376 DOI: 10.7717/Peerj.4 |
0.309 |
|
| 2013 |
Andes D. Optimizing antifungal choice and administration. Current Medical Research and Opinion. 13-8. PMID 23621589 DOI: 10.1185/03007995.2012.761135 |
0.311 |
|
| 2013 |
Desai JV, Bruno VM, Ganguly S, Stamper RJ, Mitchell KF, Solis N, Hill EM, Xu W, Filler SG, Andes DR, Fanning S, Lanni F, Mitchell AP. Regulatory role of glycerol in Candida albicans biofilm formation. Mbio. 4: e00637-12. PMID 23572557 DOI: 10.1128/Mbio.00637-12 |
0.454 |
|
| 2013 |
Mitchell KF, Taff HT, Cuevas MA, Reinicke EL, Sanchez H, Andes DR. Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms. Antimicrobial Agents and Chemotherapy. 57: 1918-20. PMID 23318790 DOI: 10.1128/Aac.02378-12 |
0.814 |
|
| 2013 |
Lee DG, Murakami Y, Andes DR, Craig WA. Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice. Antimicrobial Agents and Chemotherapy. 57: 1434-41. PMID 23295932 DOI: 10.1128/Aac.00362-12 |
0.355 |
|
| 2013 |
Craig WA, Andes DR. In vivo activities of ceftolozane, a new cephalosporin, with and without tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, including strains with extended-spectrum β-lactamases, in the thighs of neutropenic mice Antimicrobial Agents and Chemotherapy. 57: 1577-1582. PMID 23274659 DOI: 10.1128/Aac.01590-12 |
0.302 |
|
| 2013 |
Lepak AJ, Marchillo K, Vanhecker J, Andes DR. Posaconazole pharmacodynamic target determination against wild-type and Cyp51 mutant isolates of Aspergillus fumigatus in an in vivo model of invasive pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy. 57: 579-85. PMID 23147740 DOI: 10.1128/Aac.01279-12 |
0.364 |
|
| 2013 |
Tebbets B, Yu Z, Stewart D, Zhao LX, Jiang Y, Xu LH, Andes D, Shen B, Klein B. Identification of antifungal natural products via Saccharomyces cerevisiae bioassay: insights into macrotetrolide drug spectrum, potency and mode of action. Medical Mycology. 51: 280-9. PMID 22928922 DOI: 10.3109/13693786.2012.710917 |
0.422 |
|
| 2013 |
Perfect JR, Andes D. Antifungal therapy: current concepts and evidence-based management Current Medical Research and Opinion. 29: 289-290. DOI: 10.1185/03007995.2012.761136 |
0.32 |
|
| 2012 |
Dhingra S, Andes D, Calvo AM. VeA regulates conidiation, gliotoxin production, and protease activity in the opportunistic human pathogen Aspergillus fumigatus. Eukaryotic Cell. 11: 1531-43. PMID 23087369 DOI: 10.1128/Ec.00222-12 |
0.395 |
|
| 2012 |
Lepak AJ, Marchillo K, Pichereau S, Craig WA, Andes DR. Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model. Antimicrobial Agents and Chemotherapy. 56: 5916-22. PMID 22964254 DOI: 10.1128/Aac.01303-12 |
0.4 |
|
| 2012 |
Lepak A, Castanheira M, Diekema D, Pfaller M, Andes D. Optimizing Echinocandin Dosing and Susceptibility Breakpoint Determination via In Vivo Pharmacodynamic Evaluation against Candida glabrata with and without fks Mutations Antimicrobial Agents and Chemotherapy. 56: 5875-5882. PMID 22948870 DOI: 10.1128/Aac.01102-12 |
0.371 |
|
| 2012 |
Taff HT, Nett JE, Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR. A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. Plos Pathogens. 8: e1002848. PMID 22876186 DOI: 10.1371/Journal.Ppat.1002848 |
0.808 |
|
| 2012 |
Rose WE, Schulz LT, Andes D, Striker R, Berti AD, Hutson PR, Shukla SK. Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity. Antimicrobial Agents and Chemotherapy. 56: 5296-302. PMID 22869564 DOI: 10.1128/Aac.00797-12 |
0.412 |
|
| 2012 |
Andes D, Lepak A. Editorial Commentary: Antifungal Therapeutic Drug Monitoring Progress: Getting It Right the First Time Clinical Infectious Diseases. 55: 391-393. PMID 22610924 DOI: 10.1093/Cid/Cis446 |
0.37 |
|
| 2012 |
Tebbets B, Stewart D, Lawry S, Nett J, Nantel A, Andes D, Klein BS. Identification and characterization of antifungal compounds using a Saccharomyces cerevisiae reporter bioassay Plos One. 7. PMID 22574132 DOI: 10.1371/Journal.Pone.0036021 |
0.652 |
|
| 2012 |
Finkel JS, Xu W, Huang D, Hill EM, Desai JV, Woolford CA, Nett JE, Taff H, Norice CT, Andes DR, Lanni F, Mitchell AP. Portrait of Candida albicans adherence regulators. Plos Pathogens. 8: e1002525. PMID 22359502 DOI: 10.1371/Journal.Ppat.1002525 |
0.793 |
|
| 2012 |
Nett JE, Marchillo K, Andes DR. Modeling of fungal biofilms using a rat central vein catheter. Methods in Molecular Biology (Clifton, N.J.). 845: 547-56. PMID 22328403 DOI: 10.1007/978-1-61779-539-8_40 |
0.721 |
|
| 2012 |
Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell. 148: 126-38. PMID 22265407 DOI: 10.1016/J.Cell.2011.10.048 |
0.702 |
|
| 2012 |
Taff HT, Nett JE, Andes DR. Comparative analysis of Candida biofilm quantitation assays. Medical Mycology. 50: 214-8. PMID 21539503 DOI: 10.3109/13693786.2011.580016 |
0.809 |
|
| 2012 |
Nobile CJ, Fox EP, Nett JE, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. The transcriptional network controlling biofilm development in Candida albicans F1000research. 3. DOI: 10.7490/F1000Research.1194.1 |
0.644 |
|
| 2011 |
Lepak AJ, Andes DR. Antifungal PK/PD considerations in fungal pulmonary infections. Seminars in Respiratory and Critical Care Medicine. 32: 783-94. PMID 22167406 DOI: 10.1055/S-0031-1295726 |
0.378 |
|
| 2011 |
Ding C, Vidanes GM, Maguire SL, Guida A, Synnott JM, Andes DR, Butler G. Conserved and divergent roles of Bcr1 and CFEM proteins in Candida parapsilosis and Candida albicans. Plos One. 6: e28151. PMID 22145027 DOI: 10.1371/Journal.Pone.0028151 |
0.421 |
|
| 2011 |
Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE. Hsp90 governs dispersion and drug resistance of fungal biofilms. Plos Pathogens. 7: e1002257. PMID 21931556 DOI: 10.1371/Journal.Ppat.1002257 |
0.725 |
|
| 2011 |
Finkel JS, Yudanin N, Nett JE, Andes DR, Mitchell AP. Application of the systematic "DAmP" approach to create a partially defective C. albicans mutant. Fungal Genetics and Biology : Fg & B. 48: 1056-61. PMID 21820070 DOI: 10.1016/J.Fgb.2011.07.005 |
0.655 |
|
| 2011 |
Lockhart SR, Zimbeck AJ, Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Pappas PG, Chiller T. In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrobial Agents and Chemotherapy. 55: 3944-6. PMID 21670187 DOI: 10.1128/Aac.00428-11 |
0.315 |
|
| 2011 |
Nett JE, Sanchez H, Cain MT, Ross KM, Andes DR. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryotic Cell. 10: 1660-9. PMID 21666076 DOI: 10.1128/Ec.05126-11 |
0.744 |
|
| 2011 |
Lockhart SR, Wagner D, Iqbal N, Pappas PG, Andes DR, Kauffman CA, Brumble LM, Hadley S, Walker R, Ito JI, Baddley JW, Chiller T, Park BJ. Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006. Journal of Clinical Microbiology. 49: 2404-10. PMID 21562099 DOI: 10.1128/Jcm.02474-10 |
0.343 |
|
| 2011 |
Pfaller MA, Andes D, Arendrup MC, Diekema DJ, Espinel-Ingroff A, Alexander BD, Brown SD, Chaturvedi V, Fowler CL, Ghannoum MA, Johnson EM, Knapp CC, Motyl MR, Ostrosky-Zeichner L, Walsh TJ. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagnostic Microbiology and Infectious Disease. 70: 330-43. PMID 21546199 DOI: 10.1016/J.Diagmicrobio.2011.03.002 |
0.347 |
|
| 2011 |
Chen YL, Brand A, Morrison EL, Silao FG, Bigol UG, Malbas FF, Nett JE, Andes DR, Solis NV, Filler SG, Averette A, Heitman J. Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis. Eukaryotic Cell. 10: 803-19. PMID 21531874 DOI: 10.1128/Ec.00310-10 |
0.694 |
|
| 2011 |
Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, Motyl M, Perlin DS. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 14: 164-76. PMID 21353623 DOI: 10.1016/J.Drup.2011.01.004 |
0.332 |
|
| 2011 |
Andes D, Ambrose PG, Hammel JP, Van Wart SA, Iyer V, Reynolds DK, Buell DN, Kovanda LL, Bhavnani SM. Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia. Antimicrobial Agents and Chemotherapy. 55: 2113-21. PMID 21300835 DOI: 10.1128/Aac.01430-10 |
0.342 |
|
| 2011 |
Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA, Ghannoum MA, Knapp C, Lockhart SR, Ostrosky-Zeichner L, Walsh TJ, Marchillo K, Messer S, Welshenbaugh AR, Bastulli C, Iqbal N, et al. Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrobial Agents and Chemotherapy. 55: 1543-8. PMID 21282457 DOI: 10.1128/Aac.01510-09 |
0.346 |
|
| 2011 |
Nett JE, Cain MT, Crawford K, Andes DR. Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay. Journal of Clinical Microbiology. 49: 1426-33. PMID 21227984 DOI: 10.1128/Jcm.02273-10 |
0.724 |
|
| 2011 |
Lepak A, Andes D. Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting Critical Care Clinics. 27: 123-147. PMID 21144990 DOI: 10.1016/J.Ccc.2010.11.001 |
0.341 |
|
| 2010 |
Freifeld AG, Bariola JR, Andes D. The role of second-generation antifungal triazoles for treatment of the endemic mycoses. Current Infectious Disease Reports. 12: 471-478. PMID 21308557 DOI: 10.1007/S11908-010-0133-0 |
0.332 |
|
| 2010 |
Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 13: 180-95. PMID 21050800 DOI: 10.1016/J.Drup.2010.09.002 |
0.331 |
|
| 2010 |
Craig WA, Andes DR, Stamstad T. In vivo pharmacodynamics of new lipopeptide MX-2401 Antimicrobial Agents and Chemotherapy. 54: 5092-5098. PMID 20855736 DOI: 10.1128/Aac.00238-10 |
0.432 |
|
| 2010 |
Nett JE, Marchillo K, Spiegel CA, Andes DR. Development and validation of an in vivo Candida albicans biofilm denture model. Infection and Immunity. 78: 3650-9. PMID 20605982 DOI: 10.1128/Iai.00480-10 |
0.731 |
|
| 2010 |
Nett JE, Crawford K, Marchillo K, Andes DR. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrobial Agents and Chemotherapy. 54: 3505-8. PMID 20516280 DOI: 10.1128/Aac.00227-10 |
0.72 |
|
| 2010 |
Nett JE, Sanchez H, Cain MT, Andes DR. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. The Journal of Infectious Diseases. 202: 171-5. PMID 20497051 DOI: 10.1086/651200 |
0.723 |
|
| 2010 |
Andes D, Diekema DJ, Pfaller MA, Bohrmuller J, Marchillo K, Lepak A. In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species. Antimicrobial Agents and Chemotherapy. 54: 2497-506. PMID 20385855 DOI: 10.1128/Aac.01584-09 |
0.388 |
|
| 2010 |
Yu Z, Smanski MJ, Peterson RM, Marchillo K, Andes D, Rajski SR, Shen B. Engineering of Streptomyces platensis MA7339 for overproduction of platencin and congeners. Organic Letters. 12: 1744-7. PMID 20232845 DOI: 10.1021/Ol100342M |
0.351 |
|
| 2010 |
Safdar N, Smith J, Knasinski V, Sherkow C, Herrforth C, Knechtle S, Andes D. Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study Diagnostic Microbiology and Infectious Disease. 66: 7-15. PMID 19963164 DOI: 10.1016/J.Diagmicrobio.2009.08.017 |
0.301 |
|
| 2009 |
Pfaller MA, Diekema DJ, Ghannoum MA, Rex JH, Alexander BD, Andes D, Brown SD, Chaturvedi V, Espinel-Ingroff A, Fowler CL, Johnson EM, Knapp CC, Motyl MR, Ostrosky-Zeichner L, Sheehan DJ, et al. Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. Journal of Clinical Microbiology. 47: 3142-6. PMID 19692559 DOI: 10.1128/Jcm.00940-09 |
0.351 |
|
| 2009 |
Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Balajee SA, Pappas PG, Moser SA. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. Journal of Clinical Microbiology. 47: 3271-5. PMID 19692558 DOI: 10.1128/Jcm.00854-09 |
0.362 |
|
| 2009 |
Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, Andes D, Kontoyiannis DP, Perrone G, Peterson S, Brandt ME, Pappas PG, Chiller T. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. Journal of Clinical Microbiology. 47: 3138-41. PMID 19675215 DOI: 10.1128/Jcm.01070-09 |
0.34 |
|
| 2009 |
Lee I, Oh JH, Shwab EK, Dagenais TR, Andes D, Keller NP. HdaA, a class 2 histone deacetylase of Aspergillus fumigatus, affects germination and secondary metabolite production. Fungal Genetics and Biology : Fg & B. 46: 782-90. PMID 19563902 DOI: 10.1016/J.Fgb.2009.06.007 |
0.301 |
|
| 2009 |
Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, Nantel A, Andes DR, Johnson AD, Mitchell AP. Biofilm matrix regulation by Candida albicans Zap1. Plos Biology. 7: e1000133. PMID 19529758 DOI: 10.1371/Journal.Pbio.1000133 |
0.688 |
|
| 2009 |
Nett JE, Lepak AJ, Marchillo K, Andes DR. Time course global gene expression analysis of an in vivo Candida biofilm. The Journal of Infectious Diseases. 200: 307-13. PMID 19527170 DOI: 10.1086/599838 |
0.705 |
|
| 2009 |
Andes D, Craig W, Nielsen LA, Kristensen HH. In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model. Antimicrobial Agents and Chemotherapy. 53: 3003-9. PMID 19414576 DOI: 10.1128/Aac.01584-08 |
0.41 |
|
| 2009 |
Van Wart SA, Andes DR, Ambrose PG, Bhavnani SM. Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients. Diagnostic Microbiology and Infectious Disease. 63: 409-14. PMID 19249182 DOI: 10.1016/J.Diagmicrobio.2009.01.027 |
0.334 |
|
| 2009 |
Freifeld AG, Proia L, Andes D, Baddour LM, Blair J, Spellberg B, Arnold S, Lentnek A, Wheat LJ. Voriconazole Use for Endemic Fungal Infections Antimicrobial Agents and Chemotherapy. 53: 1648-1651. PMID 19139290 DOI: 10.1128/Aac.01148-07 |
0.312 |
|
| 2008 |
Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrobial Agents and Chemotherapy. 53: 24-34. PMID 18955533 DOI: 10.1128/Aac.00705-08 |
0.37 |
|
| 2008 |
Craig WA, Andes DR. In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models Antimicrobial Agents and Chemotherapy. 52: 3492-3496. PMID 18676887 DOI: 10.1128/Aac.01273-07 |
0.396 |
|
| 2008 |
Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, Andes DR, Mitchell AP. Complementary adhesin function in C. albicans biofilm formation. Current Biology : Cb. 18: 1017-24. PMID 18635358 DOI: 10.1016/J.Cub.2008.06.034 |
0.709 |
|
| 2008 |
Andes DR, Diekema DJ, Pfaller MA, Marchillo K, Bohrmueller J. In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model Antimicrobial Agents and Chemotherapy. 52: 3497-3503. PMID 18625768 DOI: 10.1128/Aac.00478-08 |
0.413 |
|
| 2008 |
Squire MW, Ludwig BJ, Thompson JR, Jagodzinski J, Hall D, Andes D. Premixed antibiotic bone cement: an in vitro comparison of antimicrobial efficacy. The Journal of Arthroplasty. 23: 110-4. PMID 18617361 DOI: 10.1016/J.Arth.2008.03.014 |
0.353 |
|
| 2008 |
Baddley JW, Patel M, Bhavnani SM, Moser SA, Andes DR. Association of fluconazole pharmacodynamics with mortality in patients with candidemia. Antimicrobial Agents and Chemotherapy. 52: 3022-8. PMID 18591269 DOI: 10.1128/Aac.00116-08 |
0.331 |
|
| 2008 |
Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, Rex JH, Alexander BD, Andes D, Brown SD, Chaturvedi V, Ghannoum MA, Knapp CC, Sheehan DJ, Walsh TJ. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. Journal of Clinical Microbiology. 46: 2620-9. PMID 18579718 DOI: 10.1128/Jcm.00566-08 |
0.36 |
|
| 2008 |
Nett JE, Guite KM, Ringeisen A, Holoyda KA, Andes DR. Reduced biocide susceptibility in Candida albicans biofilms. Antimicrobial Agents and Chemotherapy. 52: 3411-3. PMID 18573927 DOI: 10.1128/Aac.01656-07 |
0.686 |
|
| 2008 |
Vakil R, Knilans K, Andes D, Kwon GS. Combination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles Pharmaceutical Research. 25: 2056-2064. PMID 18415047 DOI: 10.1007/S11095-008-9588-1 |
0.318 |
|
| 2008 |
LaPlante KL, Leonard SN, Andes DR, Craig WA, Rybak MJ. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models. Antimicrobial Agents and Chemotherapy. 52: 2156-62. PMID 18411321 DOI: 10.1128/Aac.01046-07 |
0.384 |
|
| 2008 |
Smith J, Andes D. Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Therapeutic Drug Monitoring. 30: 167-172. PMID 18367976 DOI: 10.1097/Ftd.0B013E318167D0E0 |
0.334 |
|
| 2008 |
Uppuluri P, Nett J, Heitman J, Andes D. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrobial Agents and Chemotherapy. 52: 1127-32. PMID 18180354 DOI: 10.1128/Aac.01397-07 |
0.716 |
|
| 2008 |
Nett JE, Andes D. Review of techniques for diagnosis of catheter-related Candida biofilm infections Current Fungal Infection Reports. 2: 237-243. DOI: 10.1007/S12281-008-0035-X |
0.692 |
|
| 2007 |
Andes D, Diekema DJ, Pfaller MA, Prince RA, Marchillo K, Ashbeck J, Hou J. In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model. Antimicrobial Agents and Chemotherapy. 52: 539-50. PMID 18070979 DOI: 10.1128/Aac.01061-07 |
0.406 |
|
| 2007 |
Nett J, Lincoln L, Marchillo K, Andes D. Beta -1,3 glucan as a test for central venous catheter biofilm infection. The Journal of Infectious Diseases. 195: 1705-12. PMID 17471441 DOI: 10.1086/517522 |
0.697 |
|
| 2007 |
Li F, Svarovsky MJ, Karlsson AJ, Wagner JP, Marchillo K, Oshel P, Andes D, Palecek SP. Eap1p, an adhesin that mediates Candida albicans biofilm formation in vitro and in vivo. Eukaryotic Cell. 6: 931-9. PMID 17416898 DOI: 10.1128/Ec.00049-07 |
0.504 |
|
| 2007 |
Andes D, Craig WA. In vivo pharmacodynamic activity of the glycopeptide dalbavancin. Antimicrobial Agents and Chemotherapy. 51: 1633-42. PMID 17307987 DOI: 10.1128/Aac.01264-06 |
0.372 |
|
| 2007 |
Andes D. Pharmacokinetics and pharmacodynamics of antifungals. Infectious Disease Clinics of North America. 20: 679-97. PMID 16984875 DOI: 10.1016/J.Idc.2006.06.007 |
0.365 |
|
| 2006 |
Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, VanHandel M, Andes D. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrobial Agents and Chemotherapy. 51: 510-20. PMID 17130296 DOI: 10.1128/Aac.01056-06 |
0.73 |
|
| 2006 |
Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryotic Cell. 5: 1604-10. PMID 17030992 DOI: 10.1128/Ec.00194-06 |
0.705 |
|
| 2006 |
Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, Phan QT, Edwards JE, Filler SG, Mitchell AP. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. Plos Pathogens. 2: e63. PMID 16839200 DOI: 10.1371/Journal.Ppat.0020063 |
0.707 |
|
| 2006 |
Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Current Opinion in Microbiology. 9: 340-5. PMID 16815078 DOI: 10.1016/J.Mib.2006.06.007 |
0.737 |
|
| 2006 |
Andes D, Lepak A, Nett J, Lincoln L, Marchillo K. In vivo fluconazole pharmacodynamics and resistance development in a previously susceptible Candida albicans population examined by microbiologic and transcriptional profiling. Antimicrobial Agents and Chemotherapy. 50: 2384-94. PMID 16801416 DOI: 10.1128/Aac.01305-05 |
0.67 |
|
| 2006 |
Andes D, Forrest A, Lepak A, Nett J, Marchillo K, Lincoln L. Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. Antimicrobial Agents and Chemotherapy. 50: 2374-83. PMID 16801415 DOI: 10.1128/Aac.01053-05 |
0.645 |
|
| 2006 |
Mukherjee PK, Mohamed S, Chandra J, Kuhn D, Liu S, Antar OS, Munyon R, Mitchell AP, Andes D, Chance MR, Rouabhia M, Ghannoum MA. Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanism. Infection and Immunity. 74: 3804-16. PMID 16790752 DOI: 10.1128/Iai.00161-06 |
0.462 |
|
| 2006 |
Andes D, Craig WA. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target. Antimicrobial Agents and Chemotherapy. 50: 1376-83. PMID 16569855 DOI: 10.1128/Aac.50.4.1376-1383.2006 |
0.43 |
|
| 2006 |
Lepak A, Nett J, Lincoln L, Marchillo K, Andes D. Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole. Antimicrobial Agents and Chemotherapy. 50: 1311-9. PMID 16569846 DOI: 10.1128/Aac.50.4.1311-1319.2006 |
0.62 |
|
| 2006 |
Pfaller MA, Diekema DJ, Rex JH, Espinel-Ingroff A, Johnson EM, Andes D, Chaturvedi V, Ghannoum MA, Odds FC, Rinaldi MG, Sheehan DJ, Troke P, Walsh TJ, Warnock DW. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. Journal of Clinical Microbiology. 44: 819-26. PMID 16517860 DOI: 10.1128/Jcm.44.3.819-826.2006 |
0.32 |
|
| 2006 |
Andes D, Safdar N, Marchillo K, Conklin R. Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models. Antimicrobial Agents and Chemotherapy. 50: 674-84. PMID 16436726 DOI: 10.1128/Aac.50.2.674-684.2006 |
0.305 |
|
| 2006 |
Andes D, Craig WA. Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models. Antimicrobial Agents and Chemotherapy. 50: 243-9. PMID 16377693 DOI: 10.1128/Aac.50.1.243-249.2006 |
0.366 |
|
| 2006 |
Ashley ESD, Lewis R, Lewis JS, Martin C, Andes D. Pharmacology of Systemic Antifungal Agents Clinical Infectious Diseases. 43: S28-S39. DOI: 10.1086/504492 |
0.379 |
|
| 2005 |
Bok JW, Balajee SA, Marr KA, Andes D, Nielsen KF, Frisvad JC, Keller NP. LaeA, a regulator of morphogenetic fungal virulence factors. Eukaryotic Cell. 4: 1574-82. PMID 16151250 DOI: 10.1128/Ec.4.9.1574-1582.2005 |
0.376 |
|
| 2005 |
Andes D, Lepak A, Pitula A, Marchillo K, Clark J. A simple approach for estimating gene expression in Candida albicans directly from a systemic infection site. The Journal of Infectious Diseases. 192: 893-900. PMID 16088840 DOI: 10.1086/432104 |
0.369 |
|
| 2005 |
Tsitsigiannis DI, Bok JW, Andes D, Nielsen KF, Frisvad JC, Keller NP. Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence. Infection and Immunity. 73: 4548-59. PMID 16040966 DOI: 10.1128/Iai.73.8.4548-4559.2005 |
0.339 |
|
| 2005 |
Gauthier GM, Nork TM, Prince R, Andes D. Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: e27-8. PMID 16007519 DOI: 10.1086/431761 |
0.319 |
|
| 2005 |
Bhavnani SM, Andes DR. Gemifloxacin for the treatment of respiratory tract infections: in vitro susceptibility, pharmacokinetics and pharmacodynamics, clinical efficacy, and safety. Pharmacotherapy. 25: 717-40. PMID 15899734 DOI: 10.1592/Phco.25.5.717.63583 |
0.403 |
|
| 2005 |
Andes D. Use of an animal model of disseminated candidiasis in the evaluation of antifungal therapy. Methods in Molecular Medicine. 118: 111-28. PMID 15888938 DOI: 10.1385/1-59259-943-5:111 |
0.345 |
|
| 2005 |
Cirz RT, Chin JK, Andes DR, de Crécy-Lagard V, Craig WA, Romesberg FE. Inhibition of mutation and combating the evolution of antibiotic resistance. Plos Biology. 3: e176. PMID 15869329 DOI: 10.1371/Journal.Pbio.0030176 |
0.377 |
|
| 2005 |
Andes D. Clinical utility of antifungal pharmacokinetics and pharmacodynamics. Current Opinion in Infectious Diseases. 17: 533-40. PMID 15640707 DOI: 10.1097/00001432-200412000-00005 |
0.397 |
|
| 2005 |
Nett J, Andes D. Imaging of the Development and Therapeutic Response of an In Vivo Fungal Catheter Biofilm Microscopy Today. 13: 30-33. DOI: 10.1017/S1551929500053797 |
0.713 |
|
| 2004 |
Andes D, Nett J, Oschel P, Albrecht R, Marchillo K, Pitula A. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infection and Immunity. 72: 6023-31. PMID 15385506 DOI: 10.1128/Iai.72.10.6023-6031.2004 |
0.751 |
|
| 2004 |
Andes D. Antifungal pharmacokinetics and pharmacodynamics: understanding the implications for antifungal drug resistance. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 7: 185-94. PMID 15296860 DOI: 10.1016/J.Drup.2004.06.002 |
0.352 |
|
| 2004 |
Andes D, Anon J, Jacobs MR, Craig WA. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections. Clinics in Laboratory Medicine. 24: 477-502. PMID 15177850 DOI: 10.1016/J.Cll.2004.03.009 |
0.446 |
|
| 2004 |
Agger WA, Andes D, Burgess JW. Exophiala jeanselmei infection in a heart transplant recipient successfully treated with oral terbinafine. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 38: e112-5. PMID 15156466 DOI: 10.1086/421020 |
0.322 |
|
| 2004 |
Andes D. Clinical pharmacodynamics of antifungals. Infectious Disease Clinics of North America. 17: 635-49. PMID 14711081 DOI: 10.1016/S0891-5520(03)00063-1 |
0.335 |
|
| 2004 |
Andes D, Marchillo K, Conklin R, Krishna G, Ezzet F, Cacciapuoti A, Loebenberg D. Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis. Antimicrobial Agents and Chemotherapy. 48: 137-42. PMID 14693531 DOI: 10.1128/Aac.48.1.137-142.2004 |
0.365 |
|
| 2004 |
Safdar N, Andes D, Craig WA. In Vivo Pharmacodynamic Activity of Daptomycin Antimicrobial Agents and Chemotherapy. 48: 63-68. PMID 14693519 DOI: 10.1128/Aac.48.1.63-68.2004 |
0.371 |
|
| 2004 |
Andes D, Craig WA. Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model. Antimicrobial Agents and Chemotherapy. 47: 3935-41. PMID 14638504 DOI: 10.1128/Aac.47.12.3935-3941.2003 |
0.374 |
|
| 2004 |
Andes D, Marchillo K, Stamstad T, Conklin R. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model. Antimicrobial Agents and Chemotherapy. 47: 3165-9. PMID 14506026 DOI: 10.1128/Aac.47.10.3165-3169.2003 |
0.347 |
|
| 2003 |
Christianson JC, Engber W, Andes D. Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts Medical Mycology. 41: 177-188. PMID 12964709 DOI: 10.1080/1369378031000137224 |
0.3 |
|
| 2003 |
Andes D, Marchillo K, Stamstad T, Conklin R. In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model. Antimicrobial Agents and Chemotherapy. 47: 1193-9. PMID 12654646 DOI: 10.1128/Aac.47.4.1193-1199.2003 |
0.351 |
|
| 2003 |
Andes D, Marchillo K, Lowther J, Bryskier A, Stamstad T, Conklin R. In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model. Antimicrobial Agents and Chemotherapy. 47: 1187-92. PMID 12654645 DOI: 10.1128/Aac.47.4.1187-1192.2003 |
0.334 |
|
| 2003 |
Andes D. In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis. Antimicrobial Agents and Chemotherapy. 47: 1179-86. PMID 12654644 DOI: 10.1128/Aac.47.4.1179-1186.2003 |
0.386 |
|
| 2003 |
Crnich CJ, Gordon B, Andes D. Hot tub-associated necrotizing pneumonia due to Pseudomonas aeruginosa. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 36: e55-7. PMID 12539092 DOI: 10.1086/345851 |
0.309 |
|
| 2003 |
Andes D, van Ogtrop ML, Peng J, Craig WA. In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrobial Agents and Chemotherapy. 46: 3484-9. PMID 12384354 DOI: 10.1128/Aac.46.11.3484-3489.2002 |
0.34 |
|
| 2002 |
Jones RN, Andes DR, Mandell LA, Gothelf S, Ehrhardt AF, Nicholson SC. Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease. 44: 93-100. PMID 12376038 DOI: 10.1016/S0732-8893(02)00448-0 |
0.374 |
|
| 2002 |
Andes D, Craig WA. Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models. Antimicrobial Agents and Chemotherapy. 46: 1665-70. PMID 12019073 DOI: 10.1128/Aac.46.6.1665-1670.2002 |
0.374 |
|
| 2002 |
Andes D. Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections. Current Opinion in Infectious Diseases. 14: 165-72. PMID 11979128 DOI: 10.1097/00001432-200104000-00010 |
0.403 |
|
| 2002 |
Andes D, Craig WA. Animal model pharmacokinetics and pharmacodynamics: a critical review. International Journal of Antimicrobial Agents. 19: 261-8. PMID 11978497 DOI: 10.1016/S0924-8579(02)00022-5 |
0.356 |
|
| 2001 |
Andes D, Stamsted T, Conklin R. Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model. Antimicrobial Agents and Chemotherapy. 45: 922-6. PMID 11181381 DOI: 10.1128/Aac.45.3.922-926.2001 |
0.324 |
|
| 2001 |
Drusano GL, Preston SL, Hardalo C, Hare R, Banfield C, Andes D, Vesga O, Craig WA. Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint. Antimicrobial Agents and Chemotherapy. 45: 13-22. PMID 11120938 DOI: 10.1128/Aac.45.1.13-22.2001 |
0.376 |
|
| 2000 |
Van Ogtrop ML, Andes D, Stamstad TJ, Conklin B, Weiss WJ, Craig WA, Vesga O. In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria Antimicrobial Agents and Chemotherapy. 44: 943-949. PMID 10722495 DOI: 10.1128/Aac.44.4.943-949.2000 |
0.357 |
|
| 2000 |
Andes D, van Ogtrop M. In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model. Antimicrobial Agents and Chemotherapy. 44: 938-42. PMID 10722494 DOI: 10.1128/Aac.44.4.938-942.2000 |
0.315 |
|
| 1999 |
Andes DR, Craig WA. Pharmacokinetics and pharmacodynamics of antibiotics in meningitis Infectious Disease Clinics of North America. 13: 595-618. PMID 10470557 DOI: 10.1016/S0891-5520(05)70096-9 |
0.383 |
|
| 1999 |
Andes D, Craig WA. Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy. Infectious Disease Clinics of North America. 12: 849-60, vi. PMID 9888026 DOI: 10.1016/S0891-5520(05)70024-6 |
0.318 |
|
| 1999 |
Andes D, van Ogtrop M. Characterization and Quantitation of the Pharmacodynamics of Fluconazole in a Neutropenic Murine Disseminated Candidiasis Infection Model Antimicrobial Agents and Chemotherapy. 43: 2116-2120. DOI: 10.1128/Aac.43.9.2116 |
0.336 |
|
| 1999 |
Mouton JW, van Ogtrop ML, Andes D, Craig WA. Use of Pharmacodynamic Indices To Predict Efficacy of Combination Therapy In Vivo Antimicrobial Agents and Chemotherapy. 43: 2473-2478. DOI: 10.1128/Aac.43.10.2473 |
0.307 |
|
| 1998 |
Andes DR, Craig WA. Pharmacodynamics of fluoroquinolones in experimental models of endocarditis Clinical Infectious Diseases. 27: 47-50. PMID 9675448 DOI: 10.1086/514624 |
0.356 |
|
| 1998 |
Andes D, Craig WA. In Vivo Activities of Amoxicillin and Amoxicillin-Clavulanate against Streptococcus pneumoniae: Application to Breakpoint Determinations Antimicrobial Agents and Chemotherapy. 42: 2375-2379. DOI: 10.1128/Aac.42.9.2375 |
0.337 |
|
| 1996 |
Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. The Pediatric Infectious Disease Journal. 15: 255-9. PMID 8852915 DOI: 10.1097/00006454-199603000-00015 |
0.362 |
|
| 1995 |
Craig WA, Andes DR. Parenteral versus oral antibiotic therapy Medical Clinics of North America. 79: 497-508. PMID 7752724 DOI: 10.1016/S0025-7125(16)30052-9 |
0.342 |
|
| Show low-probability matches. |